drugset / Trial / NCT00472758
A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545
RandomizedSingle-groupDouble-blindTreatment
Summary
-To evaluate the safety and tolerability of a multiple doses of this drug in adult patients.
Timeline
- Start
- 2007-02
- Primary completion
- 2008-02
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sifalimumab | Monoclonal antibody | 1 mg/kg | Intravenous |
| Comparator | Sifalimumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Comparator | Sifalimumab | Monoclonal antibody | 30 mg/kg | Intravenous |
| Comparator | Sifalimumab | Monoclonal antibody | 3 g/kg | Intravenous |